Carmenta Bioscience

Carmenta Bioscience

Verified
Technology company focused on improving maternal and fetal health.

Launch date
Market cap
-
Net debt
-
Enterprise valuation
$8—12m (Dealroom.co estimates Aug 2013.)
Palo Alto California (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor

$0.0

round

N/A

-
Total Funding000k

Recent News about Carmenta Bioscience

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.